DB
Dashrathlal Baldevram Raval
About Dashrathlal Baldevram Raval
Data last updated:
Dashrathlal Baldevram Raval has 29 years in corporate governance. Holds Director role. Currently with 1 company, including Urja Pharmacuticls Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Urja Pharmacuticls Private Limited at ₹46,915 (FY 2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Urja Pharmacuticls Private Limited U24231GJ1983PTC006536 | Director | 02 Apr 1997 | 1983 | ₹46,915 (FY 2017) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dashrathlal Baldevram Raval
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dashrathlal Baldevram Raval
Dashrathlal Baldevram Raval has 29 years in corporate governance. Holds Director role. Currently with 1 company, including Urja Pharmacuticls Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Urja Pharmacuticls Private Limited at ₹46,915 (FY 2017).
Dashrathlal Baldevram Raval is associated with 1 company as Director, including Urja Pharmacuticls Private Limited (₹46,915).
Dashrathlal Baldevram Raval has expertise in General Business.
Dashrathlal Baldevram Raval has 29 years in corporate governance.
By reported revenue, the largest current company of Dashrathlal Baldevram Raval is Urja Pharmacuticls Private Limited, with revenue of ₹46,915 (FY 2017).
Dashrathlal Baldevram Raval currently holds positions at 1 company: Urja Pharmacuticls Private Limited (₹46,915).